Company intelligence / Profile preview

Nanjing Keppra Sheng Hui Pharmaceutical

Nanjing, Jiangsu, China

Ownership: Private
Development stage: Other

Overview

Nanjing Shenghui Pharmaceutical Co., Ltd. is a pharmaceutical distribution and wholesale company based in Nanjing, China. Founded in 2011, the company specializes in the wholesale of Chinese herbal medicines, chemical drug preparations, antibiotics, and biochemical drugs. It serves as a key regional distributor for various therapeutic products, including anti-epileptic medications like levetiracetam (marketed under the brand name Keppra). The company operates under Good Supply Practice (GSP) standards to ensure the quality and safety of its pharmaceutical supply chain across the Jiangsu province and beyond.

Therapeutic areas: NeurologyOtherInfectious Diseases
Modalities: Small moleculeBiologic
Industry: Non-Academic Healthcare

Beyond the preview

Go deeper on Nanjing Keppra Sheng Hui Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nanjing Keppra Sheng Hui Pharmaceutical.

Explore the full profile